Digital health technologies can empower patients, payers, and providers to make better-informed decisions about patient health, provide new options for facilitating prevention or early diagnosis of life-threatening diseases, and assist in the management of chronic conditions outside of traditional care settings.
Software and technologies that assist in diagnosis, treatment options, storing and sharing health records, and managing workflow can enable more efficient clinical practice.
The rise of software-driven connected technologies has created a fundamental shift in health data and information flows, and therefore, in the practice of medicine.
Digital medicine products can be used independently or in concert with pharmaceuticals, biologics, devices, or other products to optimize patient care and health outcomes. Digital medicine provides patients and healthcare providers with intelligent and accessible tools to address a wide range of conditions through high-quality, safe, and effective measurements and data-driven interventions.
Digital therapeutic products (DTx) deliver evidence-based therapeutic interventions to prevent, manage, or treat a medical disorder or disease. Clinical evidence and real-world outcomes are required for all DTx products. They are reviewed by regulatory bodies as required to support product claims of risk, efficacy, and intended use.